People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Biotechnology, Agriculture, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Summit Therapeutics Inc. | — | Biotechnology | Series D+ | $569.0M | $2.4B | 2019 |
| Enko Chem, Inc. | — | Agriculture | Series C | $127.2M | $624.4M | 2022 |
| Shoreline Biome, LLC | — | Biotechnology | Seed | $10.1M | $3.3M | 2022 |
| ReNetX Bio, Inc. | — | Biotechnology | Seed | $7.2M | $124.3M | 2019 |
| NovaTract Surgical, Inc. | — | Other Health Care | Seed | $4.9M | $14.9M | 2012 |
| Emme E2MS, LLC | — | Other Technology | Seed | $2.6M | $88.6M | 2012 |
| Bactana Corp. | — | Biotechnology | Seed | $1.7M | $5.6M | 2022 |
David Wurzer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Wurzer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Huber | 1 | 75 |
| David Jones | 1 | 19 |
| Patrick O'Neill | 1 | 14 |
| Mostafa Ronaghi | 1 | 8 |
| Peter Longo | 1 | 8 |
| Nathaniel Brinn | 1 | 7 |
| Nathaniel C. Brinn | 1 | 6 |
| Philip Austin | 1 | 5 |
| Marijn Dekkers | 1 | 4 |
| Mary Lake Polan | 1 | 4 |
| Jonathan M. Sackier | 1 | 4 |
| Robert Booth | 1 | 4 |
| Jonathan Sackier | 1 | 4 |
| David M. Wurzer | 1 | 4 |
| Gregory Ho | 1 | 4 |
| David I Scheer | 1 | 4 |
| John Kallassy | 1 | 4 |
| Jim Mellon | 1 | 4 |
| David Roblin | 1 | 3 |
| Raymond Spencer | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.